Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences
August 01, 2023 at 11:15 AM EDT
Merck's earnings were also hit by lower sales of its COVID antiviral Lagevrio.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|